🇺🇸 FDA
Pipeline program

CKD-371

A127_01BE2206

Phase 1 small_molecule completed

Quick answer

CKD-371 for Type II Diabetes Mellitus is a Phase 1 program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).

Program details

Company
Hong Kong Baptist University
Indication
Type II Diabetes Mellitus
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials